Q8VCH9
Gene name |
Lrrc3b (Lrp15) |
Protein name |
Leucine-rich repeat-containing protein 3B |
Names |
Leucine-rich repeat protein 15 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:218763 |
EC number |
|
Protein Class |
|

Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q8VCH9
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q8VCH9-F1 | Predicted | AlphaFoldDB |
22 variants for Q8VCH9
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs3389316728 | 34 | C>R | No | EVA | |
rs3389233909 | 41 | S>Y | No | EVA | |
rs3389305358 | 54 | N>Y | No | EVA | |
rs3389279659 | 80 | P>H | No | EVA | |
rs3389289651 | 86 | D>N | No | EVA | |
rs3389308895 | 90 | L>Q | No | EVA | |
rs3389303440 | 116 | Q>R | No | EVA | |
rs3404546509 | 129 | H>P | No | EVA | |
rs3404816529 | 130 | K>* | No | EVA | |
rs3404760817 | 135 | N>Y | No | EVA | |
rs3389305398 | 153 | L>I | No | EVA | |
rs3389304341 | 161 | A>V | No | EVA | |
rs3389300866 | 175 | S>* | No | EVA | |
rs3389321387 | 181 | A>D | No | EVA | |
rs3410685698 | 183 | R>G | No | EVA | |
rs3389298596 | 185 | F>L | No | EVA | |
rs3389233938 | 190 | N>K | No | EVA | |
rs3404546531 | 218 | I>T | No | EVA | |
rs3404008544 | 243 | P>L | No | EVA | |
rs3404676026 | 244 | S>G | No | EVA | |
rs3404931782 | 246 | Q>E | No | EVA | |
rs3389298676 | 247 | K>R | No | EVA |
No associated diseases with Q8VCH9
6 regional properties for Q8VCH9
Type | Name | Position | InterPro Accession |
---|---|---|---|
domain | Leucine-rich repeat N-terminal domain | 33 - 68 | IPR000372 |
repeat | Leucine-rich repeat | 69 - 111 | IPR001611-1 |
repeat | Leucine-rich repeat | 114 - 136 | IPR001611-2 |
repeat | Leucine-rich repeat, typical subtype | 67 - 86 | IPR003591-1 |
repeat | Leucine-rich repeat, typical subtype | 87 - 110 | IPR003591-2 |
repeat | Leucine-rich repeat, typical subtype | 115 - 135 | IPR003591-3 |
3 GO annotations of cellular component
Name | Definition |
---|---|
extracellular matrix | A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues. |
extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
No GO annotations of molecular function
Name | Definition |
---|---|
No GO annotations for molecular function |
No GO annotations of biological process
Name | Definition |
---|---|
No GO annotations for biological process |
5 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
A6H789 | LRRC3B | Leucine-rich repeat-containing protein 3B | Bos taurus (Bovine) | PR |
Q8IWK6 | ADGRA3 | Adhesion G protein-coupled receptor A3 | Homo sapiens (Human) | PR |
Q96PB8 | LRRC3B | Leucine-rich repeat-containing protein 3B | Homo sapiens (Human) | PR |
Q7TT36 | Adgra3 | Adhesion G protein-coupled receptor A3 | Mus musculus (Mouse) | PR |
Q9D1T0 | Lingo1 | Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 | Mus musculus (Mouse) | PR |
10 | 20 | 30 | 40 | 50 | 60 |
MNLVDLWLSR | SLSMCLLLQS | FVLMILCFHS | ASMCPKGCLC | SSSGGLNVTC | SNANLKEIPR |
70 | 80 | 90 | 100 | 110 | 120 |
DLPPETVLLY | LDSNQITSIP | NEIFKDLHQL | RVLNLSKNGI | EFIDEHAFKG | VAETLQTLDL |
130 | 140 | 150 | 160 | 170 | 180 |
SDNRIQSVHK | NAFNNLKARA | RIANNPWHCD | CTLQQVLRSM | ASNHETAHNV | ICKTSVLDEH |
190 | 200 | 210 | 220 | 230 | 240 |
AGRPFLNAAN | DADLCNLPKK | TTDYAMLVTM | FGWFTMVISY | VVYYVRQNQE | DARRHLEYLK |
250 | |||||
SLPSRQKKAD | EPDDISTVV |